Effect of a Microprocessor-controlled Prosthetic Knee Joint on K2 Level Ambulators
MPK-K2
Does a Microprocessor-Controlled Prosthetic Knee Joint Improve Mobility and Quality of Life in K2-Level Veteran Ambulators?
2 other identifiers
interventional
20
1 country
2
Brief Summary
Microprocessor-controlled knees (MPKs) automatically adjust resistance or damping in the joint to improve swing- and/or stance-phase control as appropriate for the prosthesis user during gait. The purpose of this proposed investigation is to determine if there are substantial physical and psychological benefits to fitting lower functioning Veteran ambulators having transfemoral amputations with an MPK compared with a nonmicroprocessor-controlled knee (NMPK). Using a repeated-measures, cross-sectional experimental design, approximately 20 Veterans with unilateral, transfemoral amputations will be evaluated on two separate occasions at the Jesse Brown VA Medical Center or the Edward Hines, Jr. VA Hospital, first with their conventional NMPK and then again after a 2-month accommodation period with the College Park Icon MPK.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2026
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 15, 2025
CompletedFirst Posted
Study publicly available on registry
August 5, 2025
CompletedStudy Start
First participant enrolled
May 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 30, 2028
March 19, 2026
March 1, 2026
1.8 years
July 15, 2025
March 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Walking speed
Walking speed will be measured as participants walk on level ground at slow, normal and fast speeds.
To be measured before and immediately following the 2-month accommodation period of wearing the MPK.
Falls during walking
The number of falls that occur while the subject is walking will be recorded in a daily diary.
To be determined before and during the 2-month accommodation period of wearing the MPK
PLUS-M
The Prosthetic Limb User Survey of Mobility (PLUS-M) will be used to determine the mobility of subjects before and after fitting with the MPK. Scores range from 12-60 points, and a higher score indicates greater mobility.
To be measured before and immediately following the 2-month accommodation period of wearing the MPK.
Prosthetic Knee Preference
Subjects will be asked which prosthetic knee they prefer at the completion of the study. For those that indicate preference for the MPK, they will be permitted to keep it in their prosthesis. For those that prefer the NMPK, their prosthesis will be restored to the configuration prior to beginning the study.
To be asked immediately following the 2-month accommodation period of wearing the MPK.
Secondary Outcomes (2)
ABC Scale
To be administered before and immediately following the 2-month accommodation period of wearing the MPK.
OPUS
To be administered before and immediately following the 2-month accommodation period of wearing the MPK.
Study Arms (2)
MPK
EXPERIMENTALSubjects will be fitted with the College Park ICON MPK and permitted to accommodate for 2 months prior to data collection.
NMPK
ACTIVE COMPARATORSubjects will initially be evaluated walking on their conventional NMPK as a baseline prior to being fitted with the MPK.
Interventions
Subjects will be fitted and trained on the College Park ICON MPK. An accommodation period of 2 months will be provided prior to evaluation with the knee joint.
Subjects will be tested walking with their conventional, mechanical prosthetic knee prior to being fitted with the MPK.
Eligibility Criteria
You may qualify if:
- Unilateral, transfemoral amputation (any etiology).
- Age from 45-85 years.
- Residual limb length classified as standard (i.e., medium) to long.
- Prosthesis user for at least 1 year prior to enrolling in the study.
- K2-level classification while using their NMPK.
- Good sensation on their residual limb.
- Good skin integrity upon visual inspection.
- Presents with good socket fit based upon a standard assessment by the study prosthetist.
You may not qualify if:
- Bilateral leg amputations.
- Individuals with a knee disarticulation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Jesse Brown VA Medical Center, Chicago, IL
Chicago, Illinois, 60612, United States
Edward Hines Jr. VA Hospital, Hines, IL
Hines, Illinois, 60141-3030, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Steven A Gard, PhD
Jesse Brown VA Medical Center, Chicago, IL
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 15, 2025
First Posted
August 5, 2025
Study Start
May 1, 2026
Primary Completion (Estimated)
March 1, 2028
Study Completion (Estimated)
April 30, 2028
Last Updated
March 19, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share
A Limited Dataset (LDS) will be created and shared pursuant to a Data Use Agreement (DUA) appropriately limiting use of the dataset and prohibiting the recipient from identifying or re-identifying (or taking steps to identify or re-identify) any individual whose data are included in the dataset. Results from this study will be freely disseminated via presentations at professional conferences and publications in scientific journals. Additionally, data acquired for this project will be shared with those investigators who make a formal request to the PI and can demonstrate a legitimate and justifiable cause for utilization of such data. All requests for these data will be discussed with the VA scientific program manager.